Gain Therapeutics GANX Q1 2025 earnings
Reported May 14, 2025 · Before market open
EPS-$0.16In line
Revenue estimate$25.0K
EPS estimate-$0.16
Next report
Aug 11, 2026 (In 1 week)Revenue estimate$33.3K
EPS estimate-$0.14
Versus estimates
Diluted EPS
Ask the moment Gain Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Gain Therapeutics report Q1 2025 earnings?
- Gain Therapeutics (GANX) reported Q1 2025 earnings on May 14, 2025 before market open.
- What were Gain Therapeutics's Q1 2025 revenue and EPS?
- Gain Therapeutics reported eps of $-0.16 for Q1 2025.
- Did Gain Therapeutics beat estimates in Q1 2025?
- EPS beat the consensus estimate of $-0.16 by $0.00.
- How did Gain Therapeutics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 27.3% from $-0.22.
- Where can I find Gain Therapeutics's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001558370-25-007747) directly on SEC EDGAR. The filing index links above go to sec.gov.